HomeLYEL • NASDAQ
add
Lyell Immunopharma Inc
Nakaraang pagsara
$0.67
Sakop ng araw
$0.58 - $0.68
Sakop ng taon
$0.51 - $3.14
Market cap
178.11M USD
Average na Volume
1.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 11.00K | -15.38% |
Gastos sa pagpapatakbo | 61.75M | 4.52% |
Net na kita | -191.94M | -262.62% |
Net profit margin | -1.74M | -328.55% |
Kita sa bawat share | -0.17 | 0.92% |
EBITDA | -56.72M | -5.00% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 370.53M | -32.17% |
Kabuuang asset | 490.86M | -34.55% |
Kabuuang sagutin | 108.04M | 13.63% |
Kabuuang equity | 382.82M | — |
Natitirang share | 295.23M | — |
Presyo para makapag-book | 0.52 | — |
Return on assets | -27.81% | — |
Return on capital | -29.94% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -191.94M | -262.62% |
Cash mula sa mga operasyon | -47.24M | -16.26% |
Cash mula sa pag-invest | 53.50M | 153.14% |
Cash mula sa financing | 437.00K | -42.42% |
Net change in cash | 6.70M | 104.77% |
Malayang cash flow | -5.66M | 73.34% |
Tungkol
Itinatag
2018
Headquarters
Website
Mga Empleyado
300
